ciprofloxacin has been researched along with paclitaxel in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 10 (43.48) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gibbons, S; Kaatz, GW; Zloh, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Dahse, HM; Fu, H; Grabley, S; Han, L; Huang, X; Lin, W; Moellmann, U; Sattler, I | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Wedge, DE | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Hamann, MT; Shilabin, AG | 1 |
Alla, M; Balasubramanian, S; Bommena, VR; Bommineni, MR; Mandha, SR; Siliveri, S | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arora, D; Bhushan, S; Gupta, P; Jaglan, S; Kumar, A; Kushwaha, M; Sharma, N; Sharma, V; Singamaneni, V | 1 |
Adcock, LL; Carlson, JW; Carson, LF; Carter, JR; Chen, MD; Dunn, D; Fowler, JM; Mitchell, SK; Saltzman, AK; Twiggs, LB | 1 |
Conejo, MC; García, I; Pascual, A; Perea, EJ; Salvador, J | 1 |
Carlson, JW; Carson, LF; Copeland, LJ; Fowler, JM; Mayer, AR; Mitchell, SK | 1 |
Theodoridis, G | 1 |
Edginton, A; Höhn, K; Lippert, J; Schmitt, W; Sevestre, M; Solodenko, J; Weiss, W; Willmann, S | 1 |
Bahleda, R; Cadranel, J; Ferte, C; Gomez-Roca, C; Loriot, Y; Moldovan, C; Soria, JC; Wislez, M | 1 |
Ashar, YV; Chen, ZS; Gao, HL; Gupta, P; Karadkhelkar, NM; Yoganathan, S | 1 |
2 review(s) available for ciprofloxacin and paclitaxel
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ciprofloxacin and paclitaxel
Article | Year |
---|---|
Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Bacterial Infections; Ciprofloxacin; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel | 1997 |
20 other study(ies) available for ciprofloxacin and paclitaxel
Article | Year |
---|---|
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Unusual naphthoquinone derivatives from the twigs of Avicennia marina.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Avicennia; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Mice; Molecular Structure; Naphthoquinones; Plant Stems; Plants, Medicinal; Structure-Activity Relationship | 2007 |
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
Topics: Antifungal Agents; Antineoplastic Agents; Antiparasitic Agents; Cell Line, Tumor; Depsipeptides; Drug Screening Assays, Antitumor; Fusarium; Humans; Lysosomes; Microbiological Techniques; Mycobacterium tuberculosis; Opportunistic Infections; Parasitic Sensitivity Tests; Receptor, ErbB-3; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Depsipeptides; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Microbial Sensitivity Tests; Structure-Activity Relationship | 2011 |
Eco-friendly synthesis and biological evaluation of substituted pyrano[2,3-c]pyrazoles.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Proliferation; Crystallography, X-Ray; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Conformation; Pyrazoles; Rats | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ascomycota; Cell Line, Tumor; Cell Proliferation; Datura; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Conformation; Peptides, Cyclic; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Valproic Acid | 2018 |
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Topics: Administration, Oral; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carboplatin; Chi-Square Distribution; Ciprofloxacin; Cisplatin; Costs and Cost Analysis; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukocyte Count; Middle Aged; Neutropenia; Neutrophils; Ovarian Neoplasms; Paclitaxel; Retrospective Studies | 1994 |
Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
Topics: Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Cisplatin; Doxorubicin; Fluoroquinolones; Humans; Levofloxacin; Neutrophils; Ofloxacin; Paclitaxel; Quinolones; Staphylococcus aureus | 1996 |
Application of solid-phase microextraction in the investigation of protein binding of pharmaceuticals.
Topics: Binding, Competitive; Chromatography, High Pressure Liquid; Ciprofloxacin; Haloperidol; Humans; Kinetics; Naproxen; Nortriptyline; Paclitaxel; Pharmaceutical Preparations; Protein Binding; Quinidine; Quinine; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Ultrafiltration | 2006 |
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.
Topics: Adult; Age Factors; Algorithms; Body Height; Body Mass Index; Body Weight; Ciprofloxacin; Computer Simulation; Female; Humans; Male; Metabolic Clearance Rate; Models, Biological; Paclitaxel; Pharmacokinetics; Population Surveillance; Racial Groups; Reference Values; Regional Blood Flow; Reproducibility of Results; Sex Factors; User-Computer Interface | 2007 |
Pemetrexed-induced pneumonitis: a case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Cisplatin; Drug Hypersensitivity; Drug Therapy, Combination; Dyspnea; Erythema; Glutamates; Guanine; Humans; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Pneumonia; Pulmonary Fibrosis; Recovery of Function; Solitary Pulmonary Nodule | 2009 |
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Molecular Docking Simulation; Neoplasms; Paclitaxel; Protein Binding; Up-Regulation | 2019 |